ClinicalTrials.gg
Drug

Envafolimab clinical trials

Also written KN035.

studies test it
71
open now
47
in phase 3
3
first study started
2017

How each study uses envafolimab is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the envafolimab studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Envafolimab
32
Immunotherapy
3
Envafolimab Injection
2

Development codes

KN035
16
ASC22
1

In one entry with another drug

Given together, or one or the other

Envafolimab+Lenvatinib
2

Studies by the year they started

71 studies that test it; most in 2022 (22)

Studies that test envafolimab, by start year
YearStudies
20173
20182
20192
20202
20214
202222
202316
20249
20256
20265

By phase

A phase 1/2 study counts in both.

Phase 1
5
Phase 2
64
Phase 3
3
Phase 4
1
No phase
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 13 · Other 58

3D Medicines (Sichuan) Co., Ltd. (8) · Sun Yat-sen University (6) · Tianjin Medical University Cancer Institute and Hospital (4) · Sir Run Run Shaw Hospital (3) · Fudan University (3) · Tracon Pharmaceuticals Inc. (2) · Ascletis Pharmaceuticals Co., Ltd. (2) · The First People's Hospital of Lianyungang (2)

Often tested with

Tested in the same studies.

Endostar protein (9) · Lenvatinib (7) · Surufatinib (2) · Futermestotug (1) · Tucidinostat (1) · Sacituzumab tirumotecan (1) · Axitinib (1) · CAPOX Regimen (1)

Related medicines

As reviewed, each with the page that says it.

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 18, 1 in phase 3

Studies that test envafolimab, phase 3 first.

Studies

Open first, then newest update. How each study uses envafolimab is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 71

See all 71 studies that test envafolimab →

Given beside what is tested · 6 — envafolimab is usual care or a partner of the new treatment
As the comparator · 1 — what is tested is compared with envafolimab

Codes

What other systems call envafolimab · ClinicalTrials.gg INT001692

  • MeSH (NLM) C000718749envafolimabOne source NLM
  • UNII (FDA) ES1M06M6QHENVAFOLIMABConfirmed FDA, NLM, Wikidata
  • Wikidata Q123499516envafolimabConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C129714EnvafolimabOne source FDA
  • DrugBank DB15769One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.